THE NICKLES GROUP, LLC for MERCK & CO. INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to pharmacy benefit management reforms. Issues related to vaccine policy. Issues related to supply chain and domestic manufacturing capacity.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER | — |
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Medicare/Medicaid MMM
Issues related to drug pricing and implementation of the Inflation Reduction Act. H.R. 946/S. 1862, ORPHAN Cures Act. H.R. 1492, the Ensuring Pathways to Innovative Cures Act. H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to drug pricing and pharmacy benefit management reforms. Issues related to Most Favored Nation drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER | — |
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Taxation/Internal Revenue Code TAX
H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| RACHEL JONES HENSLER | — |
Trade (domestic/foreign) TRD
Issues related to tariffs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| RACHEL JONES HENSLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.